MARKET

STTK

STTK

Shattuck Labs, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

49.50
-0.34
-0.68%
Opening 11:45 01/20 EST
OPEN
50.30
PREV CLOSE
49.84
HIGH
51.95
LOW
49.45
VOLUME
64.73K
TURNOVER
--
52 WEEK HIGH
60.52
52 WEEK LOW
17.51
MARKET CAP
1.88B
P/E (TTM)
-68.7691
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Shattuck Labs (NASDAQ:STTK) Is In A Good Position To Deliver On Growth Plans
Simply Wall St. · 01/12 10:32
DJ Shattuck Labs Initiated at Outperform by Evercore ISI Group
Dow Jones · 01/11 17:35
Shattuck Labs to Present at H.C. Wainwright BioConnect 2021 Conference
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today an...
GlobeNewswire · 01/07 22:27
Shattuck Labs to Present at H.C. Wainwright BioConnect 2021 Conference
GlobeNewswire · 01/07 22:27
Shattuck Labs to Present at 39th Annual J.P. Morgan Healthcare Conference
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today an...
GlobeNewswire · 01/06 13:23
Shattuck Labs to Present at 39th Annual J.P. Morgan Healthcare Conference
GlobeNewswire · 01/06 13:23
Shattuck Labs Added to Russell 2000® and 3000® Indexes
GlobeNewswire · 12/18/2020 23:42
Shattuck Labs to Present Virtually at Evercore ISI 3rd Annual HealthCONx Conference
GlobeNewswire · 11/25/2020 21:30
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of STTK. Analyze the recent business situations of Shattuck Labs, Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average STTK stock price target is 35.00 with a high estimate of 36.00 and a low estimate of 34.00.
EPS
Institutional Holdings
Institutions: 0
Institutional Holdings: 0
% Owned: 0.00%
Shares Outstanding: 38.08M
TypeInstitutionsShares
Increased
0
0
New
0
0
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.40%
Pharmaceuticals & Medical Research
+0.30%
Key Executives
Chairman/Co-Founder/Executive Director
Josiah Hornblower
Chief Executive Officer/Co-Founder/Director
Taylor Schreiber
Vice President - Finance/Primary Contact
Andrew Neill
Executive Officer
Casi DeYoung
Executive Officer
Lini Pandite
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About STTK
Shattuck Labs, Inc. is a clinical-stage biotechnology company. The Company is engaged in the development of dual-sided fusion proteins. The Company has created an approach to immune modulation by designing biologics with structural characteristics. Compounds derived from its Agonist Redirected Checkpoint (ARC) platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the cluster of differentiation 47/signal regulatory protein alpha (CD47/SIRPa) checkpoint interaction to restore an anti-tumor immune response and to activate the cluster of differentiation 40 (CD40) costimulatory receptor to bolster an immune response. The Company's second product candidate, SL-279252, is designed to simultaneously inhibit the programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) interaction and activate the OX40 receptor.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Shattuck Labs Inc stock information, including NASDAQ:STTK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STTK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading STTK stock methods without spending real money on the virtual paper trading platform.